Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer — Stella

Recruiting

Back to Prostate Cancer (Adenocarcinoma) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Key details

Sponsor

Fox Chase Cancer Center

Enrollment target

~80 participants

Started

September 2025

Primary completion

August 2033

Age range

18 Years and older

Sex

Male only

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov